Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07246902 · ClinicalTrials.gov registry record
Mobilization and Outcomes After Venous Closure
A clinical trial of Electrophysiology Study and Venous Vascular Closure, sponsored by Cordis US.
- Recruiting
- Registry status
- 300
- Enrollment target
- 3
- Study locations
NCT07246902 is a study of Electrophysiology Study and Venous Vascular Closure that is actively recruiting participants, run by Cordis US. The registered enrollment target is 300 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT07246902, a study of Electrophysiology Study and Venous Vascular Closure, is actively recruiting participants, sponsored by Cordis US.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 3
- Study locations
Study Summary
The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
Conditions Studied
Interventions
- DEVICE MYNX CONTROLTM VENOUS Vascular Closure Device
Study Locations (3)
Colorado
- South Denver Cardiology - Littleton
Kansas
- KC Heart and Rhythm Institute - Overland Park
North Carolina
- North Carolina Heart & Vascular Research, LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2025-11-24 |
| Est. Completion | 2026-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07246902
The ClinicalTrials.gov registry entry for NCT07246902 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cordis US, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Electrophysiology Study appearing as the primary indexed condition, and to 1 intervention - of which MYNX CONTROLTM VENOUS Vascular Closure Device is the first listed.
NCT07246902 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Colorado, Kansas, North Carolina.
Frequently Asked Questions
What is clinical trial NCT07246902 about?
NCT07246902 is a clinical study titled "Mobilization and Outcomes After Venous Closure". The primary objective of this post-market registry is to collect real-world outcomes and evaluate usage practice of MYNX CONTROL™ VENOUS (MCV) Vascular Closure Device (VCD) 6F-12F in sealing femoral venous access sites in patients who have undergone endovascular procedures in a real-world setting.
What is the current status of trial NCT07246902?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2025-11-24. Estimated completion is 2026-08.
What conditions does trial NCT07246902 study?
This clinical trial studies the following conditions: Electrophysiology Study, Venous Vascular Closure.
What interventions are being tested in trial NCT07246902?
The interventions under investigation include: MYNX CONTROLTM VENOUS Vascular Closure Device (DEVICE).
Who is sponsoring clinical trial NCT07246902?
This trial is sponsored by Cordis US, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07246902 being conducted?
This trial has 3 study locations across Colorado, Kansas, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Electrophysiology Study
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.